← Back to Clinical Trials
Recruiting NCT06648382

NCT06648382 Pilot Study of the 'Thriving With PMDs' Program

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06648382
Status Recruiting
Phase
Sponsor University of Regina
Condition Premenstrual Disorder
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2024-10-15
Primary Completion 2025-10

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 42 Years
Study Type INTERVENTIONAL
Interventions
Self-directed psychotherapy program for premenstrual disorders

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2024-10-15 with a primary completion date of 2025-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is testing a self-help mental health program that was designed to help people cope with the challenges of living with a premenstrual disorder. Individuals with a premenstrual disorder - either premenstrual dysphoric disorder or premenstrual exacerbation of depression - will track their daily symptoms for two menstrual cycles before they complete the program, throughout the two-cycle program, and for an additional two cycles after accessing the program. This will allow the research team to compare their symptoms before and after accessing the program.

Eligibility Criteria

Inclusion Criteria: * Ages 18-42 * Either meeting diagnostic criteria for premenstrual dysphoric disorder (to be confirmed by researchers through daily symptom ratings for two menstrual cycles) or major depressive disorder with perimenstrual exacerbation (i.e. at least a 30% increase in 4 symptoms in the perimenstrual phase) Exclusion Criteria: * Taking oral contraceptives * Currently in psychotherapy

Contact & Investigator

Central Contact

Jennifer Gordon, PhD

✉ jennifer.gordon@uregina.ca

📞 306-585-4389

Frequently Asked Questions

Who can join the NCT06648382 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 42 Years, studying Premenstrual Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06648382 currently recruiting?

Yes, NCT06648382 is actively recruiting participants. Contact the research team at jennifer.gordon@uregina.ca for enrollment information.

Where is the NCT06648382 trial being conducted?

This trial is being conducted at Regina, Canada, Regina, Canada.

Who is sponsoring the NCT06648382 clinical trial?

NCT06648382 is sponsored by University of Regina. The trial plans to enroll 50 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology